俄亥俄州 的 左心室功能障礙 臨床試驗
4 項針對 左心室功能障礙 的研究正在 俄亥俄州 各地點尋找參與者。
俄亥俄州 的城市
官方研究文本（英文）
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Cincinnati Children's Hospital Medical Center ( Site 0034), Cincinnati
- Cleveland Clinic-Cleveland Clinic Chidren's ( Site 0022), Cleveland
招募中2/3 期
29 Days – 17 Years · 所有性別 · 更新於 2026年8月28日 · NCT05714085A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Cincinnati Children's Hospital Medical Center | Division of Nephrology and Hypertension, Cincinnati
- Cleveland Clinic Children's, Cleveland
- Nationwide Children's Hospital - Cardiology, Columbus
招募中3 期
18 歲以下 · 所有性別 · 更新於 2026年6月29日 · NCT07192952A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Cincinnati Children's Hospital Medical Center | Division of Nephrology and Hypertension, Cincinnati
- Cleveland Clinic Children's, Cleveland
- Nationwide Children's Hospital - Cardiology, Columbus
招募中3 期
6 Months – 17 Years · 所有性別 · 更新於 2026年6月15日 · NCT07188805The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
- University Hospitals Cleveland Medical Center, Cleveland
招募中
18 歲及以上 · 所有性別 · 更新於 2026年4月28日 · NCT05427370資料來源：ClinicalTrials.gov，擷取日期 2026年10月1日。各研究自行設定資格標準；由研究團隊決定參與者資格。